Health
Could Galectin-3 be a potential biomarker to help identify severe COVID-19 early? – News-Medical.Net
Researchers have measured the galectin-3 levels in the sera of hospitalized patients. They found initial high levels indicate patients will become severely ill,…
Researchers have measured the galectin-3 levels in the sera of hospitalized patients with coronavirus disease 2019 (COVID-19). They found initial high levels indicate patients will become severely ill, suggesting it could be used as a predictor of severe disease.
As the COVID-19 pandemic continues to claim more lives, with many patients becoming severely ill, biomarkers that can predict disease severity will help better treat such patients. Patients with severe disease show a hyperinflammatory response…
-
Noosa News13 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General14 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
General22 hours agoFormer Marine Paul Doyle pleads guilty to Liverpool FC parade car ramming charges
-
Noosa News14 hours agoDepartment of Transport and Main Roads orders shutdown of North Ipswich Free Shop
